Decopharma SRL
Decopharma reported total assets of €1.36m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
The score of Decopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Decopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Decopharma's financial analysis
- Solvency80.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Decopharma
Decopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.690.808
- VAT number
- BE0471690808
- Peppol
- Registered · 0208:0471690808 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Apr 2000
- Registered office
- 9100 Sint-Niklaas
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Decopharma (SRL) has been based in Sint-Niklaas since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 166,653 € and equity of €1.10m; its revenue is not published. Its solvency stands at 80.9%, above the median of its sector (44.0%).
Companies similar to Decopharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Zuiderkruis Retail sale of pharmaceutical products Antwerp · balance sheet €1.35m
- Pharma OGZ SRL Retail sale of pharmaceutical products Brussels · balance sheet €1.35m
- Mast & CO Retail sale of pharmaceutical products Merchtem · balance sheet €1.36m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Apogrez Retail sale of pharmaceutical products Grez-Doiceau · balance sheet €1.37m
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
- EVDW Retail sale of pharmaceutical products Ghent · balance sheet €1.38m
Frequently asked questions about Decopharma
What is the revenue of Decopharma?
Decopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Decopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0471690808 for Decopharma, if the company is VAT-registered. Its company number (CBE) is 0471.690.808.
Where is the registered office of Decopharma?
According to the CBE register, the registered office of Decopharma is in 9100 Sint-Niklaas.
What is the equity of Decopharma?
At the close of the 2025 financial year, the equity of Decopharma amounts to 1,097,380 €, a solvency of 80.9% of total assets.
Who manages Decopharma?
The register lists 1 active mandates at Decopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Decopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →